BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, January 12, 2025
See today's BioWorld
Home
» Other news to note for Nov. 8, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Nov. 8, 2022
Nov. 8, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astellas, Avenue, Baergic, Bioarctic, CNBX, Fairwinds, Famygen, Fibrogen, Fortress, Fulgent Genetics, Fulgent Pharma, GSK, Merck & Co., MGFB, Nrx, Onethree, Ocuphire, Pfizer, Poolbeg, Portage, Precisionlife, Relief, Salipro, Sanofi, Sosei, Spanios, Spero, Tageza, Unravel.
BioWorld
Briefs
Other news to note
Coronavirus